BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 30300788)

  • 1. CTRP5 promotes transcytosis and oxidative modification of low-density lipoprotein and the development of atherosclerosis.
    Li C; Chen JW; Liu ZH; Shen Y; Ding FH; Gu G; Liu J; Qiu JP; Gao J; Zhang RY; Shen WF; Wang XQ; Lu L
    Atherosclerosis; 2018 Nov; 278():197-209. PubMed ID: 30300788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor I reduces lipid oxidation and foam cell formation via downregulation of 12/15-lipoxygenase.
    Sukhanov S; Snarski P; Vaughn C; Lobelle-Rich P; Kim C; Higashi Y; Shai SY; Delafontaine P
    Atherosclerosis; 2015 Feb; 238(2):313-20. PubMed ID: 25549319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein promotes atherosclerosis by increasing LDL transcytosis across endothelial cells.
    Bian F; Yang X; Zhou F; Wu PH; Xing S; Xu G; Li W; Chi J; Ouyang C; Zhang Y; Xiong B; Li Y; Zheng T; Wu D; Chen X; Jin S
    Br J Pharmacol; 2014 May; 171(10):2671-84. PubMed ID: 24517733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Known players, new interplay in atherogenesis: Chronic shear stress and carbamylated-LDL induce and modulate expression of atherogenic LR11 in human coronary artery endothelium.
    Bajari TM; Winnicki W; Gensberger ET; Scharrer SI; Regele H; Aumayr K; Kopecky C; Gmeiner BM; Hermann M; Zeillinger R; Sengölge G
    Thromb Haemost; 2014 Feb; 111(2):323-32. PubMed ID: 24284991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory Cell-Derived MYDGF Attenuates Endothelial LDL Transcytosis to Protect Against Atherogenesis.
    Xu J; Ma H; Shi L; Zhou H; Cheng Y; Tong J; Meng B; Xu X; He K; Ding S; Zhang J; Yue L; Xiang G
    Arterioscler Thromb Vasc Biol; 2023 Nov; 43(11):e443-e467. PubMed ID: 37767706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen Inhibits LDL (Low-Density Lipoprotein) Transcytosis by Human Coronary Artery Endothelial Cells via GPER (G-Protein-Coupled Estrogen Receptor) and SR-BI (Scavenger Receptor Class B Type 1).
    Ghaffari S; Naderi Nabi F; Sugiyama MG; Lee WL
    Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2283-2294. PubMed ID: 30354216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-α promotes early atherosclerosis by increasing transcytosis of LDL across endothelial cells: crosstalk between NF-κB and PPAR-γ.
    Zhang Y; Yang X; Bian F; Wu P; Xing S; Xu G; Li W; Chi J; Ouyang C; Zheng T; Wu D; Zhang Y; Li Y; Jin S
    J Mol Cell Cardiol; 2014 Jul; 72():85-94. PubMed ID: 24594319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis.
    Huang L; Chambliss KL; Gao X; Yuhanna IS; Behling-Kelly E; Bergaya S; Ahmed M; Michaely P; Luby-Phelps K; Darehshouri A; Xu L; Fisher EA; Ge WP; Mineo C; Shaul PW
    Nature; 2019 May; 569(7757):565-569. PubMed ID: 31019307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Counteractive effects of omentin-1 against atherogenesis†.
    Watanabe K; Watanabe R; Konii H; Shirai R; Sato K; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
    Cardiovasc Res; 2016 May; 110(1):118-28. PubMed ID: 26790473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low density lipoprotein receptor-related protein is required for macrophage-mediated oxidation of low density lipoprotein by 12/15-lipoxygenase.
    Xu W; Takahashi Y; Sakashita T; Iwasaki T; Hattori H; Yoshimoto T
    J Biol Chem; 2001 Sep; 276(39):36454-9. PubMed ID: 11479307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salidroside-Mediated Autophagic Targeting of Active Src and Caveolin-1 Suppresses Low-Density Lipoprotein Transcytosis across Endothelial Cells.
    Bai X; Jia X; Lu Y; Zhu L; Zhao Y; Cheng W; Shu M; Jin S
    Oxid Med Cell Longev; 2020; 2020():9595036. PubMed ID: 32685103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel assay uncovers an unexpected role for SR-BI in LDL transcytosis.
    Armstrong SM; Sugiyama MG; Fung KY; Gao Y; Wang C; Levy AS; Azizi P; Roufaiel M; Zhu SN; Neculai D; Yin C; Bolz SS; Seidah NG; Cybulsky MI; Heit B; Lee WL
    Cardiovasc Res; 2015 Nov; 108(2):268-77. PubMed ID: 26334034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolin-1 Regulates Atherogenesis by Attenuating Low-Density Lipoprotein Transcytosis and Vascular Inflammation Independently of Endothelial Nitric Oxide Synthase Activation.
    Ramírez CM; Zhang X; Bandyopadhyay C; Rotllan N; Sugiyama MG; Aryal B; Liu X; He S; Kraehling JR; Ulrich V; Lin CS; Velazquez H; Lasunción MA; Li G; Suárez Y; Tellides G; Swirski FK; Lee WL; Schwartz MA; Sessa WC; Fernández-Hernando C
    Circulation; 2019 Jul; 140(3):225-239. PubMed ID: 31154825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis.
    Stancel N; Chen CC; Ke LY; Chu CS; Lu J; Sawamura T; Chen CH
    Clin Chem; 2016 Feb; 62(2):320-7. PubMed ID: 26607724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment.
    Keiper T; Al-Fakhri N; Chavakis E; Athanasopoulos AN; Isermann B; Herzog S; Saffrich R; Hersemeyer K; Bohle RM; Haendeler J; Preissner KT; Santoso S; Chavakis T
    FASEB J; 2005 Dec; 19(14):2078-80. PubMed ID: 16195363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT6 Upregulation Promotes M2 Macrophage Polarization to Suppress Atherosclerosis.
    Gong M; Zhuo X; Ma A
    Med Sci Monit Basic Res; 2017 Jun; 23():240-249. PubMed ID: 28615615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical increase in LDL oxidation by endothelial cells from an atherosclerosis-resistant mouse strain.
    Miyoshi T; Matsumoto AH; Shi W
    Atherosclerosis; 2007 Jun; 192(2):259-65. PubMed ID: 16919636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VCAM-1-binding peptide targeted cationic liposomes containing NLRP3 siRNA to modulate LDL transcytosis as a novel therapy for experimental atherosclerosis.
    Jia X; Bai X; Yang X; Wang L; Lu Y; Zhu L; Zhao Y; Cheng W; Shu M; Mei Q; Jin S
    Metabolism; 2022 Oct; 135():155274. PubMed ID: 35917895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scavenger receptor a mediates glycated LDL transcytosis across endothelial cells to promote atherosclerosis.
    Cheng W; Shu M; Kuang L; Bai X; Jia X; Zhao Y; Lu Y; Zhu L; Wang L; Zhu Y; Shu Y; Song Y; Jin S
    Int J Biol Macromol; 2023 Apr; 235():123836. PubMed ID: 36849072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial HMGB1 Is a Critical Regulator of LDL Transcytosis via an SREBP2-SR-BI Axis.
    Ghaffari S; Jang E; Naderinabi F; Sanwal R; Khosraviani N; Wang C; Steinberg BE; Goldenberg NM; Ikeda J; Lee WL
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):200-216. PubMed ID: 33054399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.